No Data
Needham Maintains Buy on Ionis Pharmaceuticals, Lowers Price Target to $55
Ionis Pharmaceuticals Analyst Ratings
Earnings Call Summary | Ionis Pharmaceuticals(IONS.US) Q1 2025 Earnings Conference
Ionis Pharmaceuticals: Strong Q1 Performance and Promising Outlook Drive Buy Rating
Ionis Pharmaceuticals | 8-K: Ionis reports first quarter 2025 financial results
Ionis Pharmaceuticals (IONS) Reports Q1 Earnings: What Key Metrics Have to Say